Pediatrix Medical GroupFRA:PDC 52 Forward PE Ratio is 9.28 as of Jul. 12, 2026. GuruFocus rates FRA:PDC with a GF Score™ of 52/100 and a GF Value™ of €11.74 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 314 Healthcare Providers & Services companies, Pediatrix Medical Group ranks better than 77.39% on this metric.
Pediatrix Medical Group (FRA:PDC) Forward PE Ratio Explanation
The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.
Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .
Pediatrix Medical Group Forward PE Ratio Related Terms
Pediatrix Medical Group Forward PE Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pediatrix Medical Group Forward PE Ratio Chart
Pediatrix Medical Group Annual Data
Trend
2015-12
2016-12
2017-12
2018-12
2019-12
2020-12
2021-12
2022-12
2023-12
2024-12
2025-12
Forward PE Ratio
15.77
14.31
15.24
7.79
7.90
13.87
13.93
8.10
6.58
8.98
9.78
Pediatrix Medical Group Quarterly Data
2015-12
2016-12
2017-06
2017-09
2017-12
2018-03
2018-06
2018-09
2018-12
2019-03
2019-06
2019-09
2019-12
2020-03
2020-06
2020-09
2020-12
2021-03
2021-06
2021-09
2021-12
2022-03
2022-06
2022-09
2022-12
2023-03
2023-06
2023-09
2023-12
2024-03
2024-06
2024-09
2024-12
2025-03
2025-06
2025-09
2025-12
2026-03
Forward PE Ratio
15.77
14.31
16.64
10.29
15.24
15.53
10.31
10.21
7.79
7.24
6.99
6.13
7.90
4.21
12.45
7.65
13.87
19.88
26.04
16.16
13.93
11.64
10.70
7.58
8.10
9.28
8.92
7.99
6.58
7.07
5.48
8.01
8.98
8.78
7.82
8.80
9.78
9.52
FRA:PDC vs SEM, AGL, SGRY: Forward PE Ratio Comparison
For the Medical Care Facilities subindustry, Pediatrix Medical Group's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pediatrix Medical Group Forward PE Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Pediatrix Medical Group's Forward PE Ratio distribution charts can be found below:
* The bar in red indicates where Pediatrix Medical Group's Forward PE Ratio falls into.
Pediatrix Medical Group Forward PE Ratio Calculation
It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.
Pediatrix Medical Group (FRA:PDC) has a Forward PE Ratio of 9.28 as of Jul. 12, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Pediatrix Medical Group and its competitors. According to the industry distribution chart, Pediatrix Medical Group ranks #71 out of 314 companies in the Healthcare Providers & Services industry, placing it in the top 22.6%.
Is Pediatrix Medical Group's Forward PE Ratio too high?
Pediatrix Medical Group's current Forward PE Ratio is 9.28. The Healthcare Providers & Services industry median Forward PE Ratio is 18.32. Pediatrix Medical Group's value of 9.28 is 49.3% below this industry median. Based on the distribution chart, Pediatrix Medical Group ranks #71 out of 314 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Pediatrix Medical Group has a GF Score™ of 52/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Pediatrix Medical Group's Forward PE Ratio compare to SEM and AGL?
According to the Healthcare Providers & Services industry distribution chart, Pediatrix Medical Group ranks #71 out of 314 companies for Forward PE Ratio. This places Pediatrix Medical Group in the top 23% of its industry — outperforming the majority of peers. The industry median Forward PE Ratio is 18.32. Pediatrix Medical Group's value of 9.28 is 49.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Healthcare Providers & Services company?
The median Forward PE Ratio among Healthcare Providers & Services companies is 18.32, based on 314 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pediatrix Medical Group's current Forward PE Ratio of 9.28 is 49.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Pediatrix Medical Group and its competitors. For the Healthcare Providers & Services industry, the median Forward PE Ratio is 18.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pediatrix Medical Group's current Forward PE Ratio is 9.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pediatrix Medical Group stock overvalued right now?
Based on GuruFocus' analysis, Pediatrix Medical Group (FRA:PDC) is currently considered Significantly Overvalued. The stock's GF Value™ is €11.74, compared to a current price of €23.40 — trading 99.3% above its estimated fair value. The current Forward PE Ratio is 9.28 and 49.3% below the Healthcare Providers & Services industry median of 18.32. Pediatrix Medical Group's overall GF Score™ is 52/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For Pediatrix Medical Group (FRA:PDC), the current Forward PE Ratio is 9.28 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pediatrix Medical Group (FRA:PDC) Overvalued in 2026?
Based on GuruFocus' analysis, Pediatrix Medical Group stock appears to be overvalued.
The current stock price of €23.40 is trading 99.3% above its estimated GF Value™ of €11.74.
GuruFocus considers Pediatrix Medical Group to be Significantly Overvalued.
Key valuation signals for FRA:PDC:
Forward PE Ratio: 9.28
GF Value™: €11.74 vs. price of €23.40 (99.3% above fair value)
Industry Position: 49.3% below the Healthcare Providers & Services median (#71 of 314)
No single metric tells the full story. See the FRA:PDC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.
52GF Score
Get the complete analysis for FRA:PDC
Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:PDC has been successfully added to your 